Rooted in China, Global in Vision: ShineyoMedical RhythPulse® Pulsed Field Ablation System Debuts at ACAS 2026

Rooted in China, Global in Vision: ShineyoMedical RhythPulse® Pulsed Field Ablation System Debuts at ACAS 2026

立足中国，放眼世界：玄宇医疗RhythPulse®脉冲电场消融系统亮相2026 ACAS

From January 23 to 25, 2026, the 11th Asian Cardiac Arrhythmia Summit (ACAS 2026) and the 17th Chinese Cardiac Arrhythmia Summit (CCAS 2026) were successfully held in Xi’an. Organized by the Asian Heart Rhythm Association (AHRA), the summit served as a flagship academic platform that AHRA has been fostering over its 19-year history. It attracted more than 2,700 experts and scholars from 39 countries and regions worldwide, including China, the United States, Japan, South Korea, and Russia. ShineyoMedical showcased its internationally leading RhythPulse® Pulsed Field Ablation (PFA) System at the event and participated in the “Atrial Fibrillation” session, engaging in discussions with global experts on cutting‑edge advances and clinical breakthroughs in the field of cardiac arrhythmia.

2026年1月23日至25日，由亚洲心律学会（AHRA）主办的第十一届亚洲心律峰会（ACAS2026）暨第十七届中国心律失常峰会（CCAS2026）在西安隆重召开。作为亚洲心律学会创立19年来持续推动的标志性学术平台，本届峰会以古城西安为舞台，汇聚来自中国、欧洲、美国、日本、韩国、俄罗斯等39个国家和地区的2700余名专家学者。玄宇医疗携国际领先的RhythPulse®-PFA脉冲电场消融系统亮相大会“心房颤动”学术板块，与全球专家共同探讨心律失常领域的前沿进展与临床突破。

As a leading innovative medical technology company in China, ShineyoMedical’s flagship product, the RhythPulse® Pulsed Field Ablation (PFA) System, has been adopted and recognized by multiple authoritative centers across the country since its launch, thanks to its unique design. Making its debut at the ACAS Summit, the system was invited to take an in-depth part in the academic sessions, contributing several high-quality presentations focused on real-world clinical applications such as “Remarkable Case Sharing” and “Surgical Demonstrations.”
 

玄宇医疗作为国内领先的创新医疗科技企业，其核心产品RhythPulse®脉冲电场消融系统凭借独特设计，自上市以来已在国内多家权威中心投入使用并获得认可。在本届ACAS峰会上，该系统首次亮相即受邀深度参与学术环节，围绕“精彩病例分享”与“手术路演”等真实世界临床应用，贡献了多项高质量议题。

In recent years, international exchanges in the field of cardiology in China have continued to deepen. Guided by its vision of being rooted in China while embracing a global perspective, ShineyoMedical remains committed to developing valuable, leading-edge innovative clinical solutions for physicians and patients.

近年来，中国心脏病学领域的国际交流日益深化，玄宇秉持立足中国、放眼世界的理念，为医生和患者打造有价值领先的创新临床解决方案。